Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy
Gene Therapy Program, Evanston Northwestern Healthcare Research Institute and Department of Medicine, Evanston Hospital, Northwestern University, Evanston, IL 60201, USA. pseth@northwestern.edu